Oncology Institute (TOI) News Today $2.38 +0.04 (+1.71%) Closing price 06/18/2025 04:00 PM EasternExtended Trading$2.39 +0.01 (+0.42%) As of 06/18/2025 07:57 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TOI Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 Time Period The Oncology Institute, Inc. (NASDAQ:TOI) Director Sells $232,788.20 in StockJune 10, 2025 | insidertrades.comJane Street Group LLC Has $39,000 Holdings in The Oncology Institute, Inc. (NASDAQ:TOI)Jane Street Group LLC boosted its stake in The Oncology Institute, Inc. (NASDAQ:TOI - Free Report) by 613.6% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 127,659 shares of the company'sJune 10, 2025 | marketbeat.comThe Oncology Institute, Inc. (NASDAQ:TOI) Director Sells $232,788.20 in StockThe Oncology Institute, Inc. (NASDAQ:TOI - Get Free Report) Director Growth I. L.P. M33 sold 76,324 shares of the company's stock in a transaction that occurred on Thursday, June 5th. The shares were sold at an average price of $3.05, for a total transaction of $232,788.20. Following the completion of the sale, the director now owns 1,272,724 shares of the company's stock, valued at approximately $3,881,808.20. This trade represents a 5.66% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link.June 9, 2025 | marketbeat.comInsider Selling: The Oncology Institute, Inc. (NASDAQ:TOI) Director Sells 673,676 Shares of StockThe Oncology Institute, Inc. (NASDAQ:TOI - Get Free Report) Director Growth I. L.P. M33 sold 673,676 shares of the firm's stock in a transaction dated Thursday, June 5th. The stock was sold at an average price of $3.05, for a total value of $2,054,711.80. Following the completion of the transaction, the director now directly owns 13,950,557 shares in the company, valued at $42,549,198.85. The trade was a 4.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website.June 9, 2025 | marketbeat.comInsider Selling: The Oncology Institute, Inc. (NASDAQ:TOI) Director Sells 1,976,137 Shares of StockJune 6, 2025 | insidertrades.comBrad Hively Sells 1,976,137 Shares of The Oncology Institute, Inc. (NASDAQ:TOI) StockThe Oncology Institute, Inc. (NASDAQ:TOI - Get Free Report) Director Brad Hively sold 1,976,137 shares of the stock in a transaction dated Tuesday, June 3rd. The shares were sold at an average price of $2.87, for a total transaction of $5,671,513.19. Following the completion of the sale, the director now directly owns 603,501 shares in the company, valued at approximately $1,732,047.87. The trade was a 76.61% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.June 5, 2025 | marketbeat.comThe Oncology Institute set to join the Russell 2000® and Russell 3000® IndexesJune 3, 2025 | globenewswire.comShort Interest in The Oncology Institute, Inc. (NASDAQ:TOI) Increases By 26.4%The Oncology Institute, Inc. (NASDAQ:TOI - Get Free Report) was the target of a large growth in short interest in the month of May. As of May 15th, there was short interest totalling 1,870,000 shares, a growth of 26.4% from the April 30th total of 1,480,000 shares. Based on an average trading volume of 1,230,000 shares, the short-interest ratio is currently 1.5 days. Currently, 4.8% of the company's shares are short sold.June 3, 2025 | marketbeat.comOncology Institute (NASDAQ:TOI) Trading Up 2.9% - Time to Buy?Oncology Institute (NASDAQ:TOI) Trading Up 2.9% - What's Next?May 31, 2025 | marketbeat.comInsider Selling: The Oncology Institute, Inc. (NASDAQ:TOI) Director Sells 203,532 Shares of StockMay 23, 2025 | insidertrades.comOncology Institute First Quarter 2025 Earnings: US$0.25 loss per share (vs US$0.22 loss in 1Q 2024)May 16, 2025 | finance.yahoo.comOncology Institute Shares Rise After Higher 1Q RevenueMay 15, 2025 | marketwatch.comThe Oncology Institute Reports First Quarter 2025 Financial Results and Reaffirms Full Year 2025 GuidanceMay 15, 2025 | finanznachrichten.deTOI reaffirms 2025 guidance with $460M–$480M revenue target as capitation contracts fuel growthMay 15, 2025 | msn.comQ1 2025 Oncology Institute Inc Earnings CallMay 15, 2025 | finance.yahoo.comThe Oncology Institute, Inc. (TOI) Q1 2025 Earnings Call TranscriptMay 15, 2025 | seekingalpha.comThe Oncology Institute Welcomes Dr. Jeff Langsam as Chief Clinical OfficerMay 14, 2025 | globenewswire.comTopicus.com Inc. Announces Election of Members of the Board of DirectorsMay 13, 2025 | globenewswire.comThe Oncology Institute to Participate at the B. Riley Securities 25th Annual Institutional Investor ConferenceMay 13, 2025 | globenewswire.comConstellation Software Inc. and Topicus.Com Inc. Announce Results for Topicus.com Inc. for the First Quarter Ended March 31, 2025May 7, 2025 | globenewswire.comThe Oncology Institute: Insiders Buy Up Big While Valuations Are MurkyMay 6, 2025 | seekingalpha.comThe Oncology Institute, Inc.'s (NASDAQ:TOI) largest shareholders are retail investors with 40% ownership, private equity firms own 24%May 5, 2025 | uk.finance.yahoo.comTopicus.com Inc. Defers Release Date for First Quarter ResultsMay 1, 2025 | globenewswire.comOncology Institute (NASDAQ:TOI) Stock Price Up 6.3% - Still a Buy?Oncology Institute (NASDAQ:TOI) Shares Up 6.3% - Here's WhyApril 26, 2025 | marketbeat.comThe Oncology Institute Announces First Quarter 2025 Earnings Release Date and Conference CallApril 23, 2025 | globenewswire.comTopicus.com Inc. Announces Release Date for First Quarter ResultsApril 14, 2025 | globenewswire.comThe Oncology Institute, Inc. (TOI): Among Stocks Insiders Were Buying In Q1 2025April 1, 2025 | msn.comThe Oncology Institute announces launch of the Florida Oncology NetworkMarch 31, 2025 | markets.businessinsider.comTOI Launches Florida Oncology Network, a Fully Delegated Cancer Care Network, and Announces Four Additional Value-based Contracts in Q1March 31, 2025 | globenewswire.comDaniel Virnich Buys 22,640 Shares of The Oncology Institute, Inc. (NASDAQ:TOI) StockThe Oncology Institute, Inc. (NASDAQ:TOI - Get Free Report) CEO Daniel Virnich acquired 22,640 shares of the stock in a transaction dated Wednesday, March 26th. The shares were bought at an average cost of $1.04 per share, with a total value of $23,545.60. Following the completion of the transaction, the chief executive officer now owns 724,363 shares of the company's stock, valued at approximately $753,337.52. This represents a 3.23 % increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link.March 29, 2025 | marketbeat.comInsider Buying: The Oncology Institute, Inc. (NASDAQ:TOI) Director Buys 90,562 Shares of StockThe Oncology Institute, Inc. (NASDAQ:TOI - Get Free Report) Director Mark L. Pacala purchased 90,562 shares of the firm's stock in a transaction on Wednesday, March 26th. The shares were acquired at an average price of $1.04 per share, with a total value of $94,184.48. Following the completion of the acquisition, the director now owns 224,971 shares in the company, valued at approximately $233,969.84. This trade represents a 67.38 % increase in their position. The acquisition was disclosed in a filing with the SEC, which can be accessed through the SEC website.March 29, 2025 | marketbeat.comInsider Buying: The Oncology Institute, Inc. (NASDAQ:TOI) CEO Acquires 22,640 Shares of StockMarch 29, 2025 | insidertrades.comQ4 2024 Oncology Institute Inc Earnings CallMarch 26, 2025 | finance.yahoo.comOncology Institute Full Year 2024 Earnings: US$0.86 loss per share (vs US$0.92 loss in FY 2023)March 26, 2025 | uk.finance.yahoo.comThe oncology institute targets profitability and $460M-$480M revenue in 2025March 25, 2025 | msn.comThe Oncology Institute, Inc. (TOI) Q4 2024 Earnings Call TranscriptMarch 25, 2025 | seekingalpha.comOncology Institute (NASDAQ:TOI) Releases Earnings ResultsOncology Institute (NASDAQ:TOI - Get Free Report) issued its quarterly earnings data on Monday. The company reported ($0.14) EPS for the quarter. Oncology Institute had a negative return on equity of 186.83% and a negative net margin of 17.63%.March 25, 2025 | marketbeat.comThe Oncology Institute announces $16.5M private placementMarch 24, 2025 | markets.businessinsider.comThe Oncology Institute sees FY25 revenue $460M-$480MMarch 24, 2025 | markets.businessinsider.comThe Oncology Institute reports Q4 EPS (14c) vs. (21c) last yearMarch 24, 2025 | markets.businessinsider.comThe Oncology Institute Reports Fourth Quarter and Full Year 2024 Financial Results and Guidance for 2025March 24, 2025 | globenewswire.comThe Oncology Institute Announces $16.5 million Private PlacementMarch 24, 2025 | globenewswire.comFreeGulliver LLC Grows Stock Holdings in The Oncology Institute, Inc. (NASDAQ:TOI)FreeGulliver LLC lifted its stake in The Oncology Institute, Inc. (NASDAQ:TOI - Free Report) by 219.3% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 600,747 shares of the company's stock after purchasing an additional 412,578 sMarch 20, 2025 | marketbeat.comThe Oncology Institute Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference CallMarch 4, 2025 | globenewswire.comTiff Advisory Services LLC Purchases 346,256 Shares of The Oncology Institute, Inc. (NASDAQ:TOI)Tiff Advisory Services LLC raised its position in The Oncology Institute, Inc. (NASDAQ:TOI - Free Report) by 13.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,979,141 shares of the company's stock aftMarch 4, 2025 | marketbeat.comThe Oncology Institute, Inc. (NASDAQ:TOI) Short Interest Up 188.3% in FebruaryThe Oncology Institute, Inc. (NASDAQ:TOI - Get Free Report) was the target of a large increase in short interest during the month of February. As of February 15th, there was short interest totalling 934,800 shares, an increase of 188.3% from the January 31st total of 324,300 shares. Approximately 2.5% of the shares of the company are short sold. Based on an average daily trading volume, of 1,970,000 shares, the short-interest ratio is presently 0.5 days.February 28, 2025 | marketbeat.comThe Oncology Institute announces amendment to facility agreementFebruary 27, 2025 | markets.businessinsider.comThe Oncology Institute Announces Amendment to Facility Agreement and Debt PaydownFebruary 27, 2025 | markets.businessinsider.comOncology Institute (NASDAQ:TOI) Stock Price Down 6.9% - Time to Sell?Oncology Institute (NASDAQ:TOI) Trading Down 6.9% - Should You Sell?February 21, 2025 | marketbeat.comOncology Institute's Market Cap Up US$7.0m Following Year Of Insider Stock BuyingFebruary 5, 2025 | finance.yahoo.com Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter. Email Address TOI Media Mentions By Week TOI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. TOI News Sentiment▼0.000.69▲Average Medical News Sentiment TOI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. TOI Articles This Week▼02▲TOI Articles Average Week Get Oncology Institute News Delivered to You Automatically Sign up to receive the latest news and ratings for TOI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Fulgent Genetics News LifeMD News Personalis News Castle Biosciences News Fortrea News Enhabit News InnovAge News Auna News Talkspace News SBC Medical Group News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:TOI) was last updated on 6/20/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredWar-Proof Power Why This "Weird" Government Land Auction Was No Ordinary Sale When 218,000 acres of land... smack in the m...Stansberry Research | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding The Oncology Institute, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oncology Institute With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy TOI Stock Free TOI Stock Alerts